Kailera Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Kailera Therapeutics, Inc. (KLRA) is 1.44B

According to Kailera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.44B. This represents a change of -43.42% compared to the average of 2.55B of the last 4 quarters.

Kailera Therapeutics, Inc. (KLRA) Historical Enterprise Value (quarterly & annually)

How has KLRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Kailera Therapeutics, Inc. over the last ten years is 2.92B. The current 1.44B Enterprise Value has changed -50.56% with respect to the historical average. Over the past ten years (40 quarters), KLRA's Enterprise Value was at its highest in in the March 2026 quarter at 2.97B. The Enterprise Value was at its lowest in in the June 2026 quarter at 2.13B.

Kailera Therapeutics, Inc. (KLRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kailera Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kailera Therapeutics, Inc. (KLRA) Average Enterprise Value

How has KLRA Enterprise Value performed in the past?

The current Enterprise Value of Kailera Therapeutics, Inc. (KLRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kailera Therapeutics, Inc. (KLRA) Enterprise Value vs. Peers

How is KLRA’s Enterprise Value compared to its peers?

Kailera Therapeutics, Inc.’s Enterprise Value is greater than Biomea Fusion, Inc. (11.49M), less than MBX Biosciences, Inc. Common Stock (2.56B), greater than BioAge Labs Inc. (138.96M), greater than MetaVia Inc. (-4731793.00), greater than vTv Therapeutics Inc. (11.06M), less than Viking Therapeutics, Inc. (2.99B), greater than Altimmune, Inc. (368.54M), greater than Oramed Pharmaceuticals Inc. (153.75M), greater than Fractyl Health, Inc. (26.13M), less than NewAmsterdam Pharma Company N.V. (1.92B),

Build a custom stock screener for Kailera Therapeutics, Inc. (KLRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kailera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kailera Therapeutics, Inc. (KLRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kailera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.